Successful dalbavancin use in preventing reactivation of Staphylococcus aureus liver abscess during pre-engraftment neutropenia after allogeneic hematopoietic stem cell transplantation

J Chemother. 2021 Nov;33(7):517-518. doi: 10.1080/1120009X.2020.1861513. Epub 2021 Jan 18.

Authors

Gianluca Dell'Orso¹, Maura Faraci¹, Stefano Giardino¹, Marcello Mariani², Alessio Mesini², Elio Castagnola²

Affiliations

¹ Hematopoietic stem cell Transplant Unit, Department of Hematology and Oncology, IRCCS, Istituto Giannina Gaslini, Genoa, Italy.
² Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

PMID: 33459210
DOI: 10.1080/1120009X.2020.1861513

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use*
Female
Hematopoietic Stem Cell Transplantation
Humans
Liver Abscess / drug therapy*
Liver Abscess / etiology
Neutropenia / complications
Neutropenia / etiology
Staphylococcal Infections / drug therapy*
Teicoplanin / analogs & derivatives*
Teicoplanin / therapeutic use

Substances

Anti-Bacterial Agents
Teicoplanin
dalbavancin